Serum insulin concentration in dogs with insulinoma as a clinical marker for presence of metastasis at the time of diagnosis
Journal of Veterinary Internal Medicine · 2023
DOI: 10.1111/jvim.16720 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Veterinary Internal Medicine, 2023. Verfasst von Andrea Petrelli und 3 weiteren Autor:innen. Beteiligte Einrichtung: Institute of Veterinary Science, University of Liverpool, Neston, UK. Hauptthemen laut MEDLINE: Dog Diseases, Insulinoma, Pancreatic Neoplasms. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 34 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).
Abstract (Originalsprache)
Background
Information regarding serum insulin concentration in dogs newly diagnosed with insulinoma and its association with clinical stage and survival time is lacking.
Objective
Examine association between serum insulin concentration and survival and clinical disease stage in dogs with insulinoma. Animals Fifty-nine client-owned dogs with a diagnosis of insulinoma from 2 referral hospitals.
Method
Retrospective observational study. The χ2 test was used to compare the proportion of dogs with increased insulin concentration in groups with or without metastasis at the time of diagnosis. Linear mixed-effect models were built to compare differences in insulin concentration between dogs with and without evidence of metastasis at the time of original diagnosis. Cox's proportional hazards regression and Kaplan-Meier graphs were used to evaluate the association between insulin concentration and insulin groups and survival.
Results
Median serum insulin concentration was 33 mIU/L (range, 8-200 mIU/L) in dogs with World Health Organization (WHO) stage I disease and 45 mIU/L (range, 12-213 mIU/L) in dogs with WHO stage II and III disease. No difference was found in the proportion of dogs with increased insulin concentration with or without metastasis (P = .09). No association was identified between insulin concentration and survival (P = .63), and between dogs grouped by insulin concentration and survival (P = .51). Conclusions and Clinical Importance Serum insulin concentrations were not different between dogs with or without metastasis at diagnosis. The degree of insulinemia does not provide further information regarding the stage of the disease and is not associated with survival time in dogs with insulinoma.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Institute of Veterinary Science, University of Liverpool, Neston, UK.
- School of Veterinary Medicine, University of Pennsylvania, Pennsylvania, Philadelphia, USA.
ORCID-Profile: Andrea Petrelli, Alexander J German, Paolo Silvestrini
Zitieren
APA
Petrelli, A., German, A. J., O'Connell, E. M., & Silvestrini, P. (2023). Serum insulin concentration in dogs with insulinoma as a clinical marker for presence of metastasis at the time of diagnosis. Journal of Veterinary Internal Medicine. https://doi.org/10.1111/jvim.16720
Vancouver
Petrelli A, German AJ, O'Connell EM, Silvestrini P. Serum insulin concentration in dogs with insulinoma as a clinical marker for presence of metastasis at the time of diagnosis. Journal of Veterinary Internal Medicine. 2023. doi:10.1111/jvim.16720
BibTeX
@article{Petrelli2023,
author = {Petrelli, Andrea and German, Alexander J and O'Connell, Erin M and Silvestrini, Paolo},
title = {Serum insulin concentration in dogs with insulinoma as a clinical marker for presence of metastasis at the time of diagnosis},
journal = {Journal of Veterinary Internal Medicine},
year = {2023},
doi = {10.1111/jvim.16720}
}
EUVIMED